Phenotypic profiling of the human genome reveals gene products involved in plasma membrane targeting of SRC kinases

(Downloading may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.

Figure 4.
Figure 4.

Characterization and validation of PRKCA as a component in SH4-dependent protein transport. (A) HeLa cells expressing SH4-HASPB-GFP and SH4-YES1-mCherry were transfected with a scrambled siRNA (a–c), and a siRNA directed against PRKCA (d–f), and subjected to live-cell confocal microscopy to determine the localization of both SH4 fusion proteins. (B) Equal protein amounts of total cell lysates from transfected and induced cells were subjected to SDS-PAGE and Western blot analysis with antibodies directed against GFP, PRKCA, and GAPDH. (C) Stable HeLa cells expressing SH4-HASPB-GFP (a,c), or SH4-YES1-GFP (b,d), were cultured in the presence of 10 μM protein kinase C inhibitor GÖ 6983 for 16 h (c,d), and analyzed by live-cell confocal microscopy for subcellular localization of both SH4 fusion proteins.

This Article

  1. Genome Res. 21: 1955-1968

Preprint Server